Censoring refers to a situation in survival analysis where the event of interest is not observed for some of the individuals under study.

In this Statistical Primer, we’ll define three types of censoring often seen in survival analysis studies.

Censoring occurs when the information on the survival time is incomplete or only partially observed.

Censoring can have a significant impact on the analysis and interpretation of survival data. It is essential to appropriately handle censoring in survival analysis to obtain accurate estimates of survival times, covariate effects, and other related parameters.

There are different types of censoring in survival analysis:

  • Right-censoring: This occurs when a participant is still alive or event-free at the end of the study period. In other words, the follow-up time for the participant ends before the event occurs. This is the most common type of censoring in survival analysis.
  • Left-censoring: This occurs when the true event time is known to be less than a certain time, but the exact time is unknown. For example, if an individual is diagnosed with a disease before the study begins but the date of onset of the disease is not known, we have left-censoring.
  • Interval-censoring: This occurs when the event time is known to fall within a certain interval, but the exact time of the event is unknown. For example, if a person develops glaucoma in between visits to the optician but the exact onset is unknown, we have interval censoring.

Latest Resources

Tutorials

Multivariate joint longitudinal-survival models

Joint longitudinal-survival models have been widely developed, but there are many avenues of research where they are lacking in terms of methodological development, and importantly, accessible implementations. We think merlin fills a few gaps. In this post, we’ll take a look at the extension to modelling multiple continuous longitudinal outcomes, jointly with survival. For simplicity, I’ll concentrate […]
Read more

Specialist subjects

Methods Development

Methods Development We provide expert guidance in finding the appropriate statistical approach to answer your question… and if there isn’t yet a method, well, we can develop one. While applying biostatistics to address your research question is essential, there may be times when existing methods fall short for your specific problem. In such cases, we’re […]
Read more

Videos

Introduction to Epidemiological Study Designs

This video offers a comprehensive introduction to epidemiological study designs, emphasising their classification, key definitions, strengths, limitations, and practical applications. We will dive into the most commonly used study designs, exploring their structure, purpose, and the contexts in which they are most effective. Throughout the video, real-world case studies of landmark research will be used […]
Read more

Statistical Primers

What is the Cox model?

The Cox model The Cox model, also known as the proportional hazards model, is a popular statistical tool used to analyse survival data. It was developed by British statistician Sir David Cox, and published in 1972. It has gained popularity largely by avoiding making parametric assumptions about the shape of the baseline rate in a […]
Read more

Tutorials

Simulation and estimation of three-level survival models: IPD meta-analysis of recurrent event data

In this example I’ll look at the analysis of clustered survival data with three levels. This kind of data arises in the meta-analysis of recurrent event times, where we have observations (events or censored), k (level 1), nested within patients, j (level 2), nested within trials, i (level 3). Random intercepts The first example will […]
Read more

Specialist subjects

Applied Biostatistics

Applied Biostatistics Biostatistics plays a crucial role in advancing medical research. Whether it’s clinical trials, epidemiological studies, or pre-clinical research, biostatistics is essential for drawing meaningful, impactful conclusions from complex data. Our team consists of internationally recognized experts in applied biostatistics, with deep experience in a wide range of areas such as survival analysis, multi-state […]
Read more

Tutorials

Simulating survival data with a continuous time-varying covariate…the right way

In this post we’ll take a look at how to simulate survival data with a continuous, time-varying covariate. The aim is to simulate from a data-generating mechanism appropriate for evaluating a joint longitudinal-survival model. We’ll use the survsim command to simulate the survival times, and the merlin command to fit the corresponding true model. Let’s assume a proportional hazards […]
Read more

Tutorials

Joint frailty models for recurrent and terminal events

In this post we’re going to take a look at joint frailty models, and how to fit them with our merlin command. Importantly, we’ll also discuss how to interpret the results. Joint frailty models An area of intense research in recent years is in the field of joint frailty models, which has become the commonly used name for […]
Read more

Statistical Primers

What is immortal time bias?

Immortal time bias Immortal time bias is a type of bias that can occur in observational research when the study design allows for a period of time during which the outcome of interest cannot occur, often referred to as “immortal time”. Simply put, immortal time bias occurs when information from a future event is incorporated into the […]
Read more

Tutorials

multistate v4.4.0: semi-parametric multi-state modelling

The headlines: predictms now supports the Cox model as a transition model, estimated using merlin or stmerlin Predictions from a multi-state Cox model are implemented using a simulation approach Supported predictions from a multi-state Cox model include transition probabilities, probability, and length of stay, los Let’s take a look at what we can now do with multistate and in particular, the predictms command. We’ll […]
Read more

Tutorials

Joint longitudinal and competing risks models: Simulation, estimation and prediction

This post takes a look at an extension of the standard joint longitudinal-survival model, which is to incorporate competing risks. Let’s start by formally defining the model. We will assume a continuous longitudinal outcome, $$y_{i}(t) = m_{i}(t) \epsilon_{i}(t)$$ where $$m_{i}(t) = X_{1i}(t)\beta_{1} + Z_{i}(t)b_{i}$$ and \(\epsilon_{i}(t)\) is our normally distributed residual variability. We call \(m_{i}(t)\) our […]
Read more

Specialist subjects

Haematology

Haematological malignancies At Red Door Analytics, we have extensive experience in working with haematological malignancies, demonstrated through 18 publications in peer-reviewed journals. Our expertise spans epidemiological studies on prognosis and late effects, as well as randomised clinical trials. Based in Stockholm, we have unique experience in accessing and working with registry data from the Nordic […]
Read more
All Resources